ArticleScientific reports2026
Longitudinal prevalence and correlates of dynapenic abdominal obesity among community-dwelling ageing adults in rural South Africa from 2015 to 2022.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The frequency and correlates of dynapenic abdominal obesity (DAO) in ageing adults have not been assessed in a longitudinal study in sub-Saharan Africa. This study aimed to identify these characteristics and their prevalence using three-wave longitudinal data from South Africa. Data from three waves of the “Health and Ageing in Africa: A Longitudinal Study of an INDEPTH Community in South Africa (HAALSI)” (2014/2015–2022) were utilized. Community residents (≥ 40 years) with complete measurements of waist circumference and handgrip strength were included in the sample (analytic sample: n = 11073 observations). Dynapenia (= D) was defined as a handgrip strength of less than 26 kg for men and less than 16 kg for women, and abdominal obesity (= AO) a measured waist circumference (> 88 cm for women and > 102 cm for males). DAO was characterized by both AO and D using valid measures. The longitudinal relationships between independent factors and DAO, D, and AO were estimated using multinomial logistic fixed effects (FE) regressions (no D and no AO served as reference). The prevalence of DAO was 7.7% (95% CI: 7.3%-8.3%). FE logistic regressions showed that among men increases in age and among women decreases in age were associated with DAO. An increase of fruit and vegetable intake was associated with a decrease in DAO in the entire sample. In the total sample, the transition to having hypertension was positively associated with DAO in the total sample and among women. Furthermore, among women, transitioning to non-current tobacco use and increases in pain interference were associated with increases in DAO. Largely similar results were found with Cox regression and incident DAO, but an increase in age was in both men and women associated with higher hazard of incident DAO and among women depressive symptoms were associated with a higher hazard of incident DAO. The study found no significant association between transitioning to non-heavy alcohol use, diabetes, functional limitations, cardiovascular disease, living with HIV, kidney disease, impaired cognition, hospital admission, and DAO. Our knowledge of the factors that are associated with DAO is enhanced by this long-term investigation in persons 40 years of age and beyond. The work is an observational study produces some findings which are interesting but some which appear to be weak and/or contradictory. Therefore, the results are presented for information but are insufficient to draw strong conclusions at this time until future work is undertaken.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.